EC Healthcare submitted its Monthly Return for Equity Issuers to Hong Kong Exchanges and Clearing on 1 September 2026, confirming that no changes occurred in its authorised, issued or treasury share positions during August 2026.

The company’s authorised share capital remained at 38.00 billion ordinary shares with a par value of HKD 0.00001 each, equivalent to HKD 0.38 million. Issued share capital was unchanged at 1.19 billion ordinary shares, and the group continued to hold zero treasury shares as of 31 August 2026.

EC Healthcare also confirmed compliance with the Main Board’s minimum 25 percent public-float requirement.

Regarding employee incentives, the group reported 78.18 million outstanding share options across two approved schemes—18.92 million under the 2016 plan and 59.26 million under the 2023 plan. No options were exercised in August, resulting in zero new shares issued, no movement in treasury shares and no funds raised during the month.

The issuer reported no outstanding warrants, convertible securities or other share-linked instruments, and no repurchases or cancellations occurred.

Overall, EC Healthcare’s capital structure and share count were static in August 2026, with full regulatory compliance affirmed in the company’s filing.